Research & Development



  “不貪心。”陸昔年搖頭,一下撲進林徵羽的懷里,仰頭道︰“你听,神說他答應了。”   “猜的。”林徵羽動作利落地剝開蝦殼,蘸了點湯汁伸到陸昔年面前︰“我猜以他那樣喜歡出風頭的性格不會選擇打野,稍微分析了一下,覺得最有可能的地方是N港。”首页   “不用這麼著急。”陸昔年不好意思的低下頭,度蜜月什麼的還是等比賽完了再說。青娱乐   後兩條消息發送時間是一個小時以前,陸昔年那時候正錄著音,沒有第一時間看見。他翻出來又看了一遍,看著看著忍不住戳了戳林徵羽的頭像。   陸昔年收到一大堆表白私信,一臉莫名的點開,大部分寫的都是︰我們不會相信那些莫須有的東西,別太在意別人的評價,不管怎樣我都支持你們,加油,加油,加油!亚洲领先的青青草91自拍视频网站   陸昔年一口解決掉,舔舔唇覺得這酒甜甜的還挺好喝,于是晃了晃杯子還要。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo